Xingjun S. Jiang
Xiangya Road 87
Changsha, 410008, China
Changsha, 410008, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
D-wave-guided navigation in spinal cord surgery: From monitoring to decision-making
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: June 05, 2026
Hippocampus-avoidance whole-brain radiation therapy with simultaneous integrated boost for multiple brain metastases in non-small cell lung cancer: a phase Ⅱ trial
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: May 18, 2026
A Paradigm Shift in Snakebite Envenoming Therapy: From Conventional Antivenoms to Rationally Designed, Broadly Neutralizing Combination Therapies.
Journal: ACS pharmacology & translational science
Published: March 05, 2026
Physics-Informed Artificial Intelligence Design of Picomolar Nanobodies Enables Deep Tumor Penetration and High-Contrast Imaging.
Journal: Research (Washington, D.C.)
Published: February 27, 2026
ESRG maintains human pluripotent stem cell self-renewal by binding NPM1 to regulate BMP4 protein and TGF-β signaling pathway.
Journal: Cell & bioscience
Published: January 26, 2026
A multi-omics atlas reveals spatially resolved sphingolipid metabolic reprogramming after spinal cord injury.
Journal: Experimental neurology
Published: January 24, 2026
A triple combination strategy for nasopharyngeal carcinoma: Aptamer-guided liposomal chemotherapy, engineered NK cells, and Fc-enhanced PD-L1 antibody therapy.
Journal: Acta pharmaceutica Sinica. B
Published: August 13, 2025
Spatiotemporal R-loop accumulation orchestrates microenvironmental remodeling after spinal cord injury.
Journal: Neurobiology of disease
Published: July 25, 2025
Multi-omics characterization of oncosis in spinal cord injury.
Journal: Neurobiology of disease
Published: April 24, 2025
High ELK3 expression is associated with the wild type IDH1 in glioma and enhances infiltration of M2 macrophages.
Journal: International immunopharmacology
Published: February 27, 2025
ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma.
ARHGDIB as a prognostic biomarker and modulator of the immunosuppressive microenvironment in glioma.
Journal: Cancer immunology, immunotherapy : CII
Published: February 14, 2025
Pan-cancer analysis and experimental validation revealed that prognostic biomarker APOBEC3C may promote M2-type macrophage polarization and prevent R-loop accumulation in glioma.
Journal: International journal of biological macromolecules
Published: February 12, 2025
Last Updated: 09/26/2026